+251.1%
GDX vs EMR
+250.9%
+0.2%
-49.8%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 10y.
| Period | Portfolio | EMR | Excess | Alpha |
|---|---|---|---|---|
| 1D | -5.0% | -4.2% | -0.8% | -3.9% |
| 7D | -16.2% | -9.3% | -6.9% | -14.0% |
| 30D | -21.1% | -7.1% | -14.0% | -19.5% |
| 3M | -31.5% | -2.1% | -29.4% | -31.0% |
| 6M | -20.8% | +14.4% | -35.2% | -23.1% |
| YTD | -20.3% | +15.4% | -35.7% | -22.4% |
| 1Y | -5.6% | +23.8% | -29.4% | -9.3% |
| 3Y | +148.5% | +78.8% | +69.7% | +118.3% |
| 5Y | +117.7% | +78.2% | +39.5% | +89.9% |
| All | +251.1% | +250.9% | +0.2% | +187.4% |
Cumulative growth
Daily Returns
Daily percentage return beside EMR.
Daily Out/Under-Performance
Portfolio return minus EMR return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × EMR return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 10y: compounded portfolio wealth divided by compounded EMR wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
10y analysis · Full analysis span regression · 6 months rolling